Content about Zicam

The March/April 2013 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Claritin-D, Allegra-D, Zyrtec-D, Benadryl-D, Advil Allergy and Congestion Relief, UrgentRx Allergy Attack, Hyland's Seasonal Allergy Relief, Similasan's Nasal Allergy Relief and Boiron's Sabadil.

MOUNT KISCO, N.Y. — Public relations and digital marketing firm Robin Leedy and Associates has added three new clients, the firm said Tuesday.

RL&A said the clients were Matrixx Initiatives, which makes the Zicam family of pre-cold and nasal congestion products; Crosscare, which makes Colief Infant Drops for colic related to transient lactase deficiency; and Cirrus Healthcare Products, which makes EarPlanes air-pressure ear plugs, as well as AquaEars for children. The firm specializes in OTC, health and beauty aids and consumer lifestyle brands marketed to women.

The January/February 2013 Vitamins & Supplements Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Centrum, One-A-Day, NatureMade, VitaFusion, Alive, VirMax-T, MoveFree, Bioglan and Voots products.

Click here for the complete guide.

The November/December 2012 Cough, Cold and Flu Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Mucinex, Vicks, Advil, Theraflu, Delsym, St. Joseph, Hyland's Similasan and Zicam products.

Click here for the complete guide.

SKILLMAN, N.J. — Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share. The revised offer represents a premium of 51.7% over the 30-day average closing price of ProPhase's stock and a 53.7% premium to ProPhase's average closing price over the 12 months preceding Sept. 6 — the day ProPhase's former chairman and CEO, Guy Quigley, filed a Schedule 13D announcing Matrixx's purchase of a three-year option to acquire 1.45 million shares of ProPhase common stock.

DOYLESTOWN, Pa. — ProPhase Labs on Monday announced that it rejected an unsolicited, nonbinding proposal from Matrixx Initiatives to acquire the company for $1.40 per share in cash, subject to further due diligence by Matrixx.

ProPhase stock was up 20 cents to $1.39 in mid-afternoon trading.

Matrixx is the owner of the Zicam brand of cold and allergy products and is a direct competitor to ProPhase's Cold-Eeze Cold Remedy product line.

The May/June 2012 Skin/Itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Bio-Oil, AmLactin, Cetaphil Daily Advance, Zim's Crack Creme, Olay Advanced Healing, Curel Itch Defense, Benadryl Itch Relief Spray, Cortizone 10 and Neopsporin Eczema Essentials.

Click here for the complete guide.

The spring 2012 Vitamin & Supplement Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Centrum Specialist Heart, One-A-Day Women's Petites, DRS Health Complete One, Megavite Fruits & Veggies, Cosamin ASU, Omojo Acne & Tissue Support, NatureMade Krill Oil, Feosol and Slo-Niacin.

SCOTTSDALE, Ariz. — Cough-cold supplier Matrixx on Thursday credited tough comparisons against the prior season’s high pre-season inventory purchases by retailers due to the publicity of the H1N1 flu outbreak for the lower level of sales for the quarter ended Dec. 31, 2010.

The company reported net sales of $20.3 million, down 29%. However, a lift in late December cough-cold illness rates holds promise for the second half of the season.

PHOENIX Matrixx Initiatives recently introduced a new line of Zicam products — Cold Remedy Plus, a multi-ingredient formulation that both reduces the duration of the common cold and helps relieve the symptoms of someone who already has a cold.

The Cold Remedy Plus products, cherry-flavored Liqui-Loz and cherry-flavored Zavors, retail for a suggested $11.59. Two mint flavors — including a rapid melt and oral mist — will launch in the fall.